Cannabinoid Composition Ratios to Reduce THC-Induced Anxiety
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing cannabis products with THC often cause anxiety and paranoia in users, and there is a desire for lower THC content while maintaining beneficial effects.
Innovation Solution
Compositions comprising THC and cannabigerol (CBG) in specific weight ratios, along with optional terpenes, are formulated to reduce THC-induced anxiety and provide a different intoxicating effect, including smokeable, edible, and beverage forms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If THC content is increased to provide beneficial effects, then potency is improved, but anxiety and paranoia are induced
Solution Approach 1:
CBG acts as an intermediary substance that modulates THC's effects. The patent combines CBG with THC in specific ratios (1:1 to 5:1 CBG:THC) where CBG serves as a mediator that reduces the harmful psychoactive effects of THC while preserving or enhancing the beneficial effects, thereby resolving the contradiction between potency and harmful effects
Solution Approach 2:
The patent creates a composite cannabinoid formulation combining multiple cannabinoids (CBG, THC, and optionally CBD, CBC, CBN) in specific ratios. This composite approach allows the synergistic interaction between different cannabinoids to achieve the desired therapeutic effects while mitigating the harmful effects associated with high THC content alone
2Object-affected harmful factors
If THC content is reduced to eliminate anxiety, then harmful effects are reduced, but beneficial effects are diminished
Solution Approach 1:
The patent changes the compositional parameters by introducing CBG and adjusting the cannabinoid ratio. Instead of simply reducing THC, the formulation modifies the overall cannabinoid profile parameters (CBG:THC ratio, inclusion of other cannabinoids) to maintain potency while reducing harmful effects, thereby resolving the contradiction between eliminating harm and preserving benefit
3Device complexity
If single cannabinoid formulations are used, then simplicity is maintained, but user experience variability increases
Solution Approach 1:
The patent establishes homogeneous and consistent ratios of CBG to THC (specifically 1:1 to 5:1 ranges) across the formulation. This standardized homogeneous composition ensures predictable and reliable effects, reducing the variability experienced with single cannabinoid or inconsistent formulations while maintaining formulation simplicity through defined ratios
Data Source
AI summary
Compositions that include cannabinoids other than tetrahydrocannabinol (THC), such as cannabigerol (CBG) in combination with tetrahydrocannabinol (THC) or formulated to be combined with THC, and methods of preparation and use thereof are described. The compositions may be useful to reduce the risk of THC-induced anxiety and/or to produce a different intoxicating effect compared to THC alone.